Ramsay Health Care Limited reaffirms guidance, is time to buy shares?

After a sharp drop in its share price recently does today's announcement make Ramsay Health Care Limited (ASX:RHC) a bargain buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders of Ramsay Health Care Limited (ASX: RHC) can breathe a sigh of relief this morning after the private hospital operator reaffirmed its previous market guidance.

Its shares fell sharply last week after rival operator Healthscope Ltd (ASX: HSO) provided a trading update to the market which revealed that it was experiencing weakness in its hospitals segment in the first quarter of FY 2017.

Healthscope warned that if things don't pick up as the year goes on then earnings before interest, tax, depreciation, and amortisation would likely be flat year on year.

Clearly the market was fearful that Ramsay could be experiencing weakness in its own hospitals and investors sold off its shares en masse.

But thankfully this wasn't the case. According to this morning's release, Ramsay's hospitals continue to deliver admissions growth in line with its long-term trend. In light of this management advised that first quarter results are thus far meeting expectations.

For the full year Ramsay has reaffirmed its core net profit after tax and core earnings per share growth target of between 10% and 12%.

With its guidance reaffirmed it comes as no surprise to see Ramsay's share price jump today. In early trade Ramsay's share price is higher by over 3.5% to $75.

As I wrote earlier this week, I consider Ramsay to be a great buy and hold investment. Thanks to strong tailwinds from ageing populations, longer life expectancy, and increased chronic disease burden, I believe Ramsay is in a strong position for long-term growth.

At 28x estimated FY 2017's earnings its shares are by no means cheap, but I believe this is one high-quality business that justifies paying a premium to own.

With its shares still trading significantly lower than where they were before Healthscope's announcement, I think now would be a great time to make a long-term investment in the hospital giant.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »